Serial development of pulmonary hypertension in patients with idiopathic pulmonary fibrosis

被引:161
作者
Nathan, Steven D. [1 ]
Shlobin, Oksana A.
Ahmad, Shahzad
Koch, Jim
Barnett, Scott D.
Ad, Niv
Burton, Nelson
Leslie, Kevin [2 ]
机构
[1] Inova Fairfax Hosp, Inova Heart & Vasc Inst, Adv Lung Dis & Lung Transplant Program, Falls Church, VA 22042 USA
[2] Mayo Clin, Scottsdale, AZ USA
关键词
pulmonary fibrosis; pulmonary hypertension; lung transplantation; pulmonary function tests;
D O I
10.1159/000114246
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Idiopathic pulmonary fibrosis ( IPF) is a disease with very high mortality. Objective: We sought to characterize serial changes in pulmonary artery pressures ( PAP) in patients with advanced IPF who survive to transplant. Methods: Retrospective analysis of IPF patients comparing mean PAP at the time of initial evaluation for transplantation ( mPAP baseline) with mPAP at the time of transplant ( mPAP follow-up). The measurements were correlated with New York Heart Association ( NYHA) functional class and oxygen requirements. Results: The final cohort consisted of 44 patients with serial right heart catheterization data. The mean mPAP baseline and mPAP follow-up were 22.5 and 32.7 mm Hg, respectively. 38.6% ( 17/44) of the patients had pulmonary hypertension ( PH) at baseline. The majority of the non-PH patients developed PH during the serial time interval with a subsequent incidence of 77.8%. At the time of transplant, 86.4% of the patients had PH. There was a significant association between transplant NYHA class, severity of PH and oxygen requirements. Transplant NYHA class IV patients had a higher rate of mPAP change. The severity of PH at the time of transplant did not affect transplant outcomes. Conclusion: PH is common and progressive in patients with advanced IPF who are transplant candidates. Serial change and severity of PAP elevations have a significant association with oxygen requirements and functional status, but not transplant outcomes. Whether or not progressive PH has a significant impact on outcomes without transplantation requires further study. Copyright (C) 2008 S. Karger AG, Basel.
引用
收藏
页码:288 / 294
页数:7
相关论文
共 30 条
[1]   Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease [J].
Arcasoy, SM ;
Christie, JD ;
Ferrari, VA ;
Sutton, MS ;
Zisman, DA ;
Blumenthal, NP ;
Pochettino, A ;
Kotloff, RM .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (05) :735-740
[2]   Sitaxsentan therapy for pulmonary arterial hypertension [J].
Barst, RJ ;
Langleben, D ;
Frost, A ;
Horn, EM ;
Oudiz, R ;
Shapiro, S ;
McLaughlin, V ;
Hill, N ;
Tapson, VF ;
Robbins, IM ;
Zwicke, D ;
Duncan, B ;
Dixon, RAF ;
Frumkin, LR .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 169 (04) :441-447
[3]   A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension [J].
Barst, RJ ;
Rubin, LJ ;
Long, WA ;
McGoon, MD ;
Rich, S ;
Badesch, DB ;
Groves, BM ;
Tapson, VF ;
Bourge, RC ;
Brundage, BH ;
Koerner, SK ;
Langleben, D ;
Keller, CA ;
Murali, S ;
Uretsky, BF ;
Clayton, LM ;
Jobsis, MM ;
Blackburn, SD ;
Shortino, D ;
Crow, JW .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :296-301
[4]   Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis [J].
Bjoraker, JA ;
Ryu, JH ;
Edwin, MK ;
Myers, JL ;
Tazelaar, HD ;
Schroeder, DR ;
Offord, KP .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (01) :199-203
[5]  
BOVILL JG, 1993, CARDIAC ANESTHESIA, P467
[6]   CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling [J].
Burdick, MD ;
Murray, LA ;
Keane, MP ;
Xue, YY ;
Zisman, DA ;
Belperio, JA ;
Strieter, RM .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (03) :261-268
[7]   Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis [J].
Collard, HR ;
King, TE ;
Bartelson, BB ;
Vourlekis, JS ;
Schwarz, MI ;
Brown, KK .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (05) :538-542
[8]   Pigment epithelium - derived factor in idiopathic pulmonary fibrosis - A role in aberrant angiogenesis [J].
Cosgrove, GP ;
Brown, KK ;
Schiemann, WP ;
Serls, AE ;
Parr, JE ;
Geraci, MW ;
Schwarz, MI ;
Cool, CD ;
Worthen, GS .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (03) :242-251
[9]   Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis [J].
Ebina, M ;
Shimizukawa, M ;
Shibata, N ;
Kimura, Y ;
Suzuki, T ;
Endo, M ;
Sasano, H ;
Kondo, T ;
Nukiwa, T .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 169 (11) :1203-1208
[10]   Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia [J].
Flaherty, KR ;
Mumford, JA ;
Murray, S ;
Kazerooni, EA ;
Gross, BH ;
Colby, TV ;
Travis, WD ;
Flint, A ;
Toews, GB ;
Lynch, JP ;
Martinez, FJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (05) :543-548